The future of biopharma and health tech
“๐ป๐ ๐๐๐ ๐๐๐ ๐๐๐๐๐ ๐๐๐๐๐๐๐๐ ๐๐ ๐๐๐๐๐๐ ๐ ๐๐๐๐ ๐๐๐ ๐๐๐๐๐๐๐๐ ๐๐ ๐ ๐๐๐๐๐๐๐.” – โจย Carl Jung
In light of the upcoming Pulse Network meeting, please see the below article by myself and Jovita Balcaitiene, MD that highlights some of the global trends in the healthcare industry impacting the future for patients, as well as some critical questions as we enter 2025.
New Partnership: HealthTech For Care’s HealthTech Innovation Days
Exciting news : Pulse Network is a partner of HealthTech For Care’s HealthTech Innovation Days (HTID)! This European event (Sept 17th & 18th in Paris) serves as a platform for innovation and science stakeholders. More info and register here: https://www.healthtechinnovationdays6.com/
The Economist Impact CGT Summit
Explore the insights from the Economist Impactโs CGT 2024 Summit, where industry experts addressed key challenges in the introduction of CGTs, including regulatory, manufacturing, supply chain, clinical, scientific, and commercial aspects. See the white paper from the events capturing important themes and takeaways from the summit, including regulatory changes and new delivery models, the need to keep conversations and practices focused on patients, and how to structure clinical trials, gather real world evidence and streamline manufacturing to help improve access to treatment.
A pause to focus on “becoming”
Mid-week inspiration from Jerry Seinfeld’s Duke commencement speech: I’m taking a pause to focus on “becoming” rather than “having”, including a friend’s prestigious award at a biopharma company, and a new project for Pulse Edge.
Economist Impactโs CGT Summit: Regulatory frameworks
At the Economist Impactโs Cell and Gene Therapy (CGT) Summit last month, experts from across the industry discussed numerous topics and challenges in the introduction of CGTs:
๐ Regulatory
๐ Manufacturing and supply chain
๐ Clinical and scientific
๐ Commercial
One of the major challenges facing the industry is the complexity and variability of regulatory frameworks, which can impact the development and commercialization of CGTs.
Some highlights from speakers regarding ๐ฅ๐ฒ๐ด๐๐น๐ฎ๐๐ผ๐ฟ๐ ๐ณ๐ฟ๐ฎ๐บ๐ฒ๐๐ผ๐ฟ๐ธ๐.
The Economist Impactโs Cell and Gene Therapy Summit
The Economist Impactโs Cell and Gene Therapy Summit gathered international thought leaders last month in Brussels.
They covered diverse themes related to a core question:
๐ How must the market evolve to sufficiently incentivize and support the development of transformative advanced therapies?
Pulse: Bringing innovation and connecting curious minds
Back from a whirlwind trip to the USA, Hannah shares her thoughts on Pulse Edge and Pulse Network…over a cup of chai latte.
World EPA: Empowering patients to collect their outcomes to achieve value-based healthcare
Great panel on empowering patients to collect their outcomes to realise value-based healthcare.
Day 1 of the World Evidence, Pricing and Access Congress is a wrap!
It was a pleasure reconnecting with former colleagues, making new contacts, and seeing the various minds in action during sessions yesterday.
Missed our Pulse Network March event?ย
Catch some highlights here ๐ซ
